Our Science – Hughes Website
Stephen H. Hughes, Ph.D.
Selected Publications |
 |
| 1)
Das K, Arnold E, Hughes S. Lennarz W, Lane M, eds. HIV-1 reverse transcriptase structures. In: Encyclopedia of Biological Chemistry. .: Elsevier; 2013. p. 548-553 [Book Chapter] |
|
| 2)
Johnson B, Metifiot M, Ferris A, Pommier Y, Hughes S. A homology model of HIV-1 integrase and analysis of mutations designed to test the model. J Mol Biol. 425: 2133-2146, 2013. Full Text Article. [Journal] |
|
| 3)
Metifiot M, Maddali K, Johnson BC, Hare S, Smith SJ, Zhao XZ, Marchand C, Burke TR, Hughes SH, Cherepanov P, Pommier Y. Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase. ACS Chem. Biol. 8: 209-17, 2013. [Journal] |
|
| 4)
Koh Y, Wu X, Ferris AL, Matreyek KA, Smith SJ, Lee K, Kewalramani VN, Hughes SH, Engelman A. Differential Effects of Human Immunodeficiency Virus Type 1 Capsid and Cellular Factors Nucleoporin 153 and LEDGF/p75 on the Efficiency and Specificity of Viral DNA Integration. J. Virol. 87: 648-58, 2013. [Journal] |
|
| 5)
Lauberth SM, Nakayama T, Wu X, Ferris AL, Tang Z, Hughes SH, Roeder RG. H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation. Cell. 152: 1021-36, 2013. [Journal] |
|
| 6)
Li Y, Ferris A, Lewis B, Orsulic S, Williams B, Holland E, Hughes S. The RCAS/TVA somatic gene transfer method in modeling human cancer. In: Genetically Engineered Mice for Cancer Research: Design, Analysis, Pathways, Validation and Pre-clinical Testing (Green, J.E., and Ried, T., eds,). -: Springer Publications; 2012. p. 83-112 [Book Chapter] |
|
| 7)
Zhao XZ, Maddali K, Smith SJ, Métifiot M, Johnson BC, Marchand C, Hughes SH, Pommier Y, Burke TR. 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors. Bioorg. Med. Chem. Lett. 2012. [Journal] |
|
| 8)
Johnson BC, Pauly GT, Rai G, Patel D, Bauman JD, Baker HL, Das K, Schneider JP, Maloney DJ, Arnold E, Thomas CJ, Hughes SH. A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. Retrovirology. 9: 99, 2012. Full Text Article. [Journal] |
|
| 9)
Zhao XZ, Maddali K, Metifiot M, Smith SJ, Vu BC, Marchand C, Hughes SH, Pommier Y, Burke TR. Bicyclic Hydroxy-1H-pyrrolopyridine-trione Containing HIV-1 Integrase Inhibitors. Chem Biol Drug Des. 79: 157-165, 2012. [Journal] |
|
| 10)
Boyer PL, Clark PK, Hughes SH. HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors. J. Virol. 86: 5885-94, 2012. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 5/24/2013.
